WP
Woodline Partners Portfolio holdings
AUM
$18.9B
This Quarter Return
-2.82%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$15.4B
AUM Growth
+$15.4B
(+4.1%)
Cap. Flow
+$1.37B
Cap. Flow
% of AUM
8.93%
Top 10 Holdings %
Top 10 Hldgs %
12.37%
Holding
1,071
New
155
Increased
511
Reduced
205
Closed
180
Top Buys
| 1 |
Hartford Financial Services
HIG
|
$93.4M |
| 2 |
Electronic Arts
EA
|
$91.9M |
| 3 |
Apple
AAPL
|
$85.2M |
| 4 |
Zscaler
ZS
|
$70.3M |
| 5 |
SBA Communications
SBAC
|
$65.7M |
Top Sells
| 1 |
Arthur J. Gallagher & Co
AJG
|
$191M |
| 2 |
TE Connectivity
TEL
|
$127M |
| 3 |
Take-Two Interactive
TTWO
|
$90M |
| 4 |
CNX Resources
CNX
|
$72M |
| 5 |
Microchip Technology
MCHP
|
$71.5M |
Sector Composition
| 1 | Healthcare | 29.86% |
| 2 | Technology | 22.26% |
| 3 | Financials | 10.01% |
| 4 | Consumer Discretionary | 7.78% |
| 5 | Industrials | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
IBM
IBM
$227B
| $44.9M | 0.29% |
180,388
+129,726
| +256% | +$32.3M |
|
102
Exxon Mobil
XOM
$477B
| $43.7M | 0.28% |
367,764
+103,820
| +39% | +$12.3M |
|
103
Protagonist Therapeutics
PTGX
$3.62B
| $43.4M | 0.28% |
897,699
+315,372
| +54% | +$15.3M |
|
104
Zai Lab
ZLAB
$3.48B
| $43.4M | 0.28% |
1,201,016
-558,781
| -32% | -$20.2M |
|
105
Trex
TREX
$6.41B
| $42.9M | 0.28% |
739,052
+426,561
| +137% | +$24.8M |
|
106
First Industrial Realty Trust
FR
$6.87B
| $42.9M | 0.28% |
795,709
+513,505
| +182% | +$27.7M |
|
107
Chord Energy
CHRD
$6.12B
| $42.8M | 0.28% |
380,045
-368,921
| -49% | -$41.6M |
|
108
Warrior Met Coal
HCC
$2.93B
| $42.7M | 0.28% |
894,938
+224,558
| +33% | +$10.7M |
|
109
Uber
UBER
$194B
| $42.4M | 0.28% |
581,435
+567,089
| +3,953% | +$41.3M |
|
110
CDW
CDW
$21.4B
| $42.3M | 0.28% |
+264,145
| New | +$42.3M |
|
111
Alnylam Pharmaceuticals
ALNY
$58.6B
| $42.2M | 0.27% |
+156,464
| New | +$42.2M |
|
112
Vaxcyte
PCVX
$4.17B
| $42M | 0.27% |
1,111,777
-9,145
| -0.8% | -$345K |
|
113
Boston Scientific
BSX
$159B
| $41.1M | 0.27% |
407,886
-74,567
| -15% | -$7.52M |
|
114
UnitedHealth
UNH
$279B
| $40.7M | 0.26% |
77,751
+25,094
| +48% | +$13.1M |
|
115
Ryan Specialty Holdings
RYAN
$7.04B
| $40.3M | 0.26% |
+545,254
| New | +$40.3M |
|
116
Arcus Biosciences
RCUS
$1.24B
| $40.2M | 0.26% |
5,127,304
+1,603,367
| +45% | +$12.6M |
|
117
Krystal Biotech
KRYS
$4.35B
| $40M | 0.26% |
222,043
+941
| +0.4% | +$170K |
|
118
Apogee Therapeutics
APGE
$2.27B
| $39.6M | 0.26% |
1,061,053
+45,445
| +4% | +$1.7M |
|
119
Eaton
ETN
$134B
| $39.5M | 0.26% |
145,303
+129,559
| +823% | +$35.2M |
|
120
Domino's
DPZ
$15.8B
| $39.4M | 0.26% |
85,704
+60,337
| +238% | +$27.7M |
|
121
Janux Therapeutics
JANX
$1.38B
| $39.3M | 0.26% |
1,457,095
-395,092
| -21% | -$10.7M |
|
122
Penumbra
PEN
$10.5B
| $39M | 0.25% |
145,881
+120,558
| +476% | +$32.2M |
|
123
Pure Storage
PSTG
$25.5B
| $39M | 0.25% |
+880,707
| New | +$39M |
|
124
Americold
COLD
$3.95B
| $38.4M | 0.25% |
1,791,513
+536,435
| +43% | +$11.5M |
|
125
Mastercard
MA
$536B
| $37.7M | 0.25% |
68,804
+19,578
| +40% | +$10.7M |
|